Where does Shifamed Holdings, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Shifamed Holdings, LLC ranks #4,487 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Shifamed Holdings, LLC hold?

Shifamed Holdings, LLC holds 79 US utility patents granted between 2016 and 2025, spanning 17 technology areas.

What is Shifamed Holdings, LLC's Innovation Score?

Shifamed Holdings, LLC has an Innovation Score of 53.7 out of 100 (top 9% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Shifamed Holdings, LLC's patent grant rate increasing or decreasing?

Shifamed Holdings, LLC's recent grant velocity is +308% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Shifamed Holdings, LLC's patents?

Shifamed Holdings, LLC's patents average 20.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Shifamed Holdings, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Shifamed Holdings, LLC

Q: What technology areas does Shifamed Holdings, LLC focus on?

Shifamed Holdings, LLC's top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 47 patents, ranking #129 of 3,082 assignees active in that subclass. Grants appear in 17 CPC subclasses total.

USPTO PatentsView assignee record - 79 granted patents across 17 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Shifamed ranks #4,487 of 49,997 tracked US assignees by granted-patent volume, with 79 patents across 17 technology areas.

#4,487
of 49,997 US assignees by volume: Top 9%
by Innovation Score (53.7/100): 20.5
avg claims per patent: +308%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4487 · US Corporation #4,487 · 79 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 79 grants
TOP-DECILE #4,487/49,997
PHOTO-FINISH Ranpak
CPC-FOCUS A61F · 17 areas
INNOV-PAR 53.7/100
CLAIMS-DENSE 20.5 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +308% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ranpak Corp. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Shifamed’s 53.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 15.1 pts (28%) Velocity 11.7 pts (22%) Breadth 14.6 pts (27%) Claim depth 12.3 pts (23%)

Qualcomm Incorporated · highest

85
Databricks · near

54
rewardStyle · near

54
Saluda Medical Pty · near

54
Shifamed Holdings · this assignee

54
Stellenbosch… · near

54
3D Lighting… · lowest

7

What this shows Shifamed's Innovation Score is 53.7/100 (top 9% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Shifamed?

Each dot is one of Shifamed’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Shifamed’s own 20.5 claims/patent is ABOVE the 15.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Shifamed vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Shifamed's grants concentrate

Shifamed Holdings, LLC is a focused PatentsView assignee: 17 CPC subclasses with 59.5% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2023 (14 grants) versus a trough of 1 in 2016. By volume, Shifamed sits between Ranpak Corp. and The University Court of the University of Edinburgh.

Shifamed's three-year grant acceleration

From 2019–2021 to 2022–2024, Shifamed Holdings, LLC moved from 20 to 35 grants (1.75x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Ranpak

79
SK Siltron

79
SK ie technology

79
Savant Systems

79
TE Connectivity N…

79
Tesla Motors

79
Thales Avionics

79
The University Co…

79
Shifamed Holdings ◀

79

What this shows Shifamed holds 79 patents at rank #4,489, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Shifamed

By rank, the assignees closest to #4,489 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Shifamed's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Shifamed, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Shifamed ranks #129 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (54 here).

Saluda Medical Pty Ltd 54 Stellenbosch University 54 Databricks, Inc. 54 rewardStyle, Inc. 54

Similar claim depth

Nearest assignees by average claims per patent (20.5 here).

BSH Bosch und Siemens Hausgeräte GmbH 20.5 avg Ansys, Inc. 20.5 avg IonQ, Inc. 20.5 avg Coherent Logix, Incorporated 20.5 avg

Shifamed's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

54 Top 9% higher than 91% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Shifamed Holdings, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	1.3%
2017	4	5.1%
2018	1	1.3%
2019	6	7.6%
2020	5	6.3%
2021	9	11.4%
2022	8	10.1%
2023	14	17.7%
2024	13	16.5%
2025partial year	18	22.8%

Which technologies does Shifamed Holdings, LLC patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 47

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 41

A61B - DIAGNOSIS; SURGERY; Identification 23

B29D - Producing Particular Articles From Plastics OR From Substances IN A Plastic State 7

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 6

C08L - Compositions OF Macromolecular Compounds 5

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 3

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 3

B32B - Layered Products, i.e. Products Built-up OF Strata OF Flat OR Non-flat, e.g. Cellular OR Honeycomb, Form 3

B21D - Working OR Processing OF Sheet Metal OR Metal Tubes, Rods OR Profiles Without Essentially Removing MATERIAL; Punching Metal 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

E02D - FOUNDATIONS; EXCAVATIONS; Embankments ; Underground OR Underwater Structures 1

G02B - Optical Elements, Systems OR Apparatus 1

G01S - Radio DIRECTION-FINDING; Radio NAVIGATION; Determining Distance OR Velocity BY USE OF Radio WAVES; Locating OR Presence-detecting BY USE OF THE Reflection OR Reradiation OF Radio WAVES; Analogous Arrangements Using Other Waves 1

Y10T - Technical Subjects Covered BY Former US Classification 1

Top 15 of 17 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Shifamed Holdings, LLC's patent record in context - here's where to go next.

Shifamed Holdings, LLC's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 59.5% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #4,487 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Shifamed Holdings, LLC against Ranpak Corp., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 53.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.